Immunopotentiators in modern vaccines / Virgil E.J.C. Schijns, Derek T. O'Hagan.
Publication details: Amsterdam ; Boston : Elsevier Academic Press, c2006.Description: xi, 371 p. : ill. ; 26 cmISBN:- 0120884038 (alk. paper)
- 9780120884032 (alk. paper)
- 615.372 22 SCH
- QW 805
Item type | Current library | Call number | Copy number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Book Open Access | Health Sciences Library | 615.372 SCH 1 (Browse shelf(Opens below)) | 1 | Available | MBAL22021387 |
Contents
Contents
Part I. Perspective on Immunological mechanisms underlying adjuvant activity
1) Unravelling "the immunologist's dirty little secret"
Virgil Schijns
Part II. Host-derived immunopotentiators
2) Dendritic cells as targets and tools in vaccines
Filippo Belardelli, Imerio Capone and Paoloa Rizza
3) Host derived molecules and antibodies against them as adjuvants
Tom Barr, Jennifer Carlring, Andrew W. Heath,
Part III. Natural and synthetic immunopotentiators
4) Immune potentiator mechanisms
Nick Valiante
5) CpG Oligodeoxynucleotides as vaccine adjuvants
Michael J. McCluskie and Risini D. Weeratna
6) Toll-like receptor 4 agonists as vaccine adjuvants
David Persing, Patrick McGowan, Jay T. Evans, Christopher Cluff, Sally Mossman, David Johnson and Jory R. Baldridge
7) Immunomodulatory adjuvants from Quillaja saponaria
Charlotte Read Kensil
Part IV. Particulate immunopotentiators and delivery systems
8) Microparticles as vaccine delivery systems
Derek T. O'Hagan
9) MF59: A safe and potent adjuvant for human use
Audino Podda , Giuseppe Del Guidice and Derek T. O'Hagan
10) Development and evaluation of AS04, an novel an improved adjuvant system containing MPL and aluminium salt
Nathalie Garcon, Marcelle van Mechelen and Martine Wettendorf
11) Virosomes for vaccine delivery
Ian C. Metcalfe and Reinhard Gluck
12) The ISCOMATRIXTM adjuvant
Debbie Drane and Martin Pearse
13) Mineral adjuvants
Erik B. Lindblad
Part V. Mucosal/ non-parenteral adjuvants
14) Mucosal Adjuvants Based On Cholera Toxin and Escherichia Coli Heat-Labile Enterotoxin
Jan Holmgren
15) Transcutaneous Immunization using the Heat-labile Enterotoxin of E. coli as an Adjuvant
Richard T. Kenney and Gregory M. Glenn
VI. Th-1/ CTL adjuvants
16) T cell adjuvants and novel strategies for their identification
Philippe Moingeon
Part VII. Adjuvants in non-infectious disease vaccines
17) Vaccination to treat non-infectious diseases: surveying the opportunities
Stephen W. Martin and Martin F Bachmann
Part VIII. Clinical Practice
18) Clinical evaluation of adjuvants
Robert Edelman and Jakub K Simon
19) Non-clinical safety assessment of vaccines
Elizabeth M Sutkowski and Marion F Gruber
Includes bibliographical references and index.
There are no comments on this title.